Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Moderna New Supply Agreement with Israel for 2022
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a […]
Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement with Zentalis Pharmaceuticals
Gain Therapeutics, Inc. today announced a multi-target collaboration agreement with Zentalis Pharmaceuticals to discover new product candidates […]
RETINA-AI Health Awarded U.S. Patent for AI Eye Disease Detection
RETINA-AI Health Inc. has been awarded a U.S. patent on its Artificial Intelligence (AI) systems […]
Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development
Medable Inc. today announced $78 million in new funding to fuel advances in the delivery […]
Oregon Oncology Specialists Integrate AI-screening Solution VIPER™ Into Network
Deep Lens and Oregon Oncology Specialists today announced a strategic collaboration that will integrate Deep […]
Festival Republic Joins Government Pilot Programme with a Live Event to Trial the Safe Return of Fans
The Sefton Park Pilot, in partnership with Culture Liverpool, will further trial approaches to managing […]
Huma and RARE-X Partner to Accelerate Research for 9,500 Rare Diseases
Huma, Europe’s fastest-growing health technology company, is partnering with the non-profit patient advocacy group RARE-X, which runs […]
Novavax to Participate in Comparing Mixed COVID-19 Vaccine Combinations
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its […]
First Digital Vaccine Card Service VaxYes Converts 10,000 COVID Vaccine Cards Into Digital Vaccine Certificates
GoGetVax, the country’s first end-to-end COVID-19 vaccine technology platform, has successfully helped its first 10,000 users […]
Next Phase of Vaccine Roll-Out
The UK is moving into the next phase of the COVID-19 vaccine programme as the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more